BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10920185)

  • 1. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
    Claassen GF; Hann SR
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
    Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
    Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
    Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
    Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
    J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
    Mitchell KO; El-Deiry WS
    Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
    Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H
    Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21WAF1/CIP1 and G2/M arrest.
    Evdokiou A; Raggatt LJ; Atkins GJ; Findlay DM
    Mol Endocrinol; 1999 Oct; 13(10):1738-50. PubMed ID: 10517675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
    Terada Y; Okado T; Inoshita S; Hanada S; Kuwahara M; Sasaki S; Yamamoto T; Marumo F
    Kidney Int; 2001 May; 59(5):1706-16. PubMed ID: 11318941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1.
    Hermeking H; Funk JO; Reichert M; Ellwart JW; Eick D
    Oncogene; 1995 Oct; 11(7):1409-15. PubMed ID: 7478565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
    Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
    Günes C; Lichtsteiner S; Vasserot AP; Englert C
    Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.